Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice

Scandinavian Journal of Gastroenterology

Volumn 38, Issue 8, 2003, Pages 837-844

  Takagi, H ^b   Kanai, T ^b   Okazawa, A ^b   Kishi, Y ^b   Sato, T ^b   Takaishi, H ^b   Inoue, N ^b   Ogata, H ^b   Iwao, Y ^b   Hoshino, K ^b   Takeda, K ^b   Akira, S ^b   Watanabe, M ^b   Ishii, H ^b   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY   (Japan)

^b NONE

Author keywords

DSS; IL 12; IL 18; Murine colitis

Indexed keywords

DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOCHEZIA; HISTOLOGY; HISTOPATHOLOGY; LAMINA PROPRIA; LETHALITY; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL; WEIGHT REDUCTION;

ANIMALS; COLITIS; COLON; DEXTRAN SULFATE; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; MICE; MICE, MUTANT STRAINS; MONOCYTES; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0041426439     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520310004047     Document Type: Article

References (28)

1. Asseman C, Fowler S, Powrie F. Control of experimental inflammatory bowel disease by regulatory T cells. Am J Respir Crit Care Med 2000;162:185-9.
2. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann Rev Immunol 1995;13:251-76.
3. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NF-kB. Immunity 1997;7:571-81.
4. Okamura H, Tsutsui H, Komatsu M, Yutsudo M, Hakura A, Tanimoto T, et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995;378:88-91.
5. Dinarello CA. Interleukin-18. Methods 1999;19:121-32.
6. Bazan JF, Timans JC, Kastelein RA. A newly defined interleukin-1? Nature 1996;379:591.
7. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto T, et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998;8:383-90.
8. Hoshino T, Yagita H, Ortaldo JR, Wiltout RH, Young HA. In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4 + T cells. Eur J Immunol 2000;30:1998-2006.
9. Yoshimoto T, Tsutsui H, Ominaga K, Hoshino K, Okamura H, Akira S, et al. IL-18, although antiallergic when administrated with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci USA 1999;96:13962-6.
10. Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F, et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997;112:1169-78.
11. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995;182:1281-90.
12. Pizarro TT, Michie MH, Bentz M, Woraratanadharm J, Smith MF, Jr, Foley E, et al. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol 1999;162:6829-35.
13. Monteleone G, Trapasso F, Parrello T, Biancone L, Stella A, Iuliano R, et al. Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol 1999;163:143-7.
14. Kanai T, Watanabe M, Okazawa A, Nakamaru K, Okamoto M, Naganuma M, et al. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease. Gastroenterology 2000;119:1514-23.
15. Siegmund B, Fantuzzi G, Rieder F, Gamboni-Robertson F, Lehr HA, Hartmann G, et al. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol 2001;281:1264-73.
16. Kanai T, Watanabe M, Okazawa A, Sato T, Yamazaki M, Okamoto S, et al. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterology 2001;121:875-88.
17. Ten Hove T, Corbaz A, Amitai H, Aloni S, Belzer I, Graber P, et al. Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice. Gastroenterology 2001;121:1372-9.
18. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
19. Hoshino K, Kawase Y, Okamoto M, Yokota K, Yoshino K, Yamamura K, et al. Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J Immunol 1999;162:5041-4.
20. Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Bahin R, et al. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 1996;26:1553-9.
21. Cooper HS, Murphy SNS, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-49.
22. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994;107:1643-52.
23. Hans W, Scholmerich J, Gross V, Falk W. Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice. Eur Cytokine Netw 2000;11:67-74.
24. Davidson NJ, Hudak SA, Lesley RE, Menon S, Leach MW, Rennick DM. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J Immunol 1998;161:3143-9.
25. Camoglio L, Juffermans NP, Peppelenbosch M, te Velde AA, te Kate FJ, SJHvan Deventer, et al. Contrasting roles of IL-12p40 and IL-12p35 in the development of hapten-induced colitis. Eur J Immunol 2002;32:261-9.
26. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG, et al. Chronic experimental colitis induced by dextran sulfate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998;114:385-91.
27. Axelsson LG, Landstrom E, Goldschmidt TJ, Gronberg A, Bylund-Fellenius AC. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+)-cell depleted, athymic and NK-cell depleted SCID mice. Inflamm Res 1996;45:181-91.
28. Kampfer H, Kalina U, Muhl H, Pfeilschifer J, Frank S. Counter-regulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice. J Invest Dermatol 1999;113:369-74.